For example, in the early stage of breast cancer, the expression of S100A4 with that of either hepatocyte growth factor receptor (HGFR) or osteopontin (OPN) was an indicator of tumor metastasis and poor prognosis [60]. This evidence concerns the gene S100A4 and breast cancer.